Clinical Study
Full-Thickness Retinochoroidal Incision in the Management of Central Retinal Vein Occlusion
Table 1
Demographic data of patients.
| | Perfusion statue | Duration of symptoms (months) | Preoperative Snellen BCVA | Postoperative Snellen BCVA | Preoperative CMT (μm) | Postoperative CMT (μm) | Number of RCVA formation | Complication |
| 1/F/75 | I | 3 | 1/20 | 4/200 | 277 | 213 | 1 | None | 2/M/58 | I | 4 | HM | 4/200 | 388 | 93 | 1 | VH + NVG | 3/M/60 | I | 6 | 4/200 | 4/200 | 445 | 138 | 2 | None | 4/F/72 | I | 10 | 4/200 | 4/200 | 309 | 182 | 1 | None | 5/F/63 | N | 4 | 4/20 | 8/20 | 502 | 381 | 2 | None | 6/F/74 | I | 5 | 4/200 | 4/200 | 753 | 229 | 1 | VH | 7/F/45 | I | 5 | 4/200 | 4/200 | 358 | 283 | 2 | None | 8/M/58 | I | 4 | 4/200 | 1/20 | 409 | 343 | 1 | None | 9/F/41 | I | 4 | 1/20 | 1/20 | 328 | 148 | 2 | None | 10/F/63 | N | 9 | 4/200 | 4/200 | 392 | 201 | 2 | None | 11/F/50 | N | 4 | 1/20 | 10/20 | 409 | 230 | 2 | None | 12/F/59 | N | 6 | 1/20 | 6/20 | 574 | 325 | 1 | None | 13/M/73 | I | 3 | 2/20 | 4/200 | 749 | 160 | 3 | VH | 14/M/66 | I | 3 | 2/200 | 2/200 | 562 | 202 | 1 | VH + PFM | 15/F/73 | N | 3 | 2/20 | 16/20 | 414 | 225 | 1 | None | 16/M/62 | I | 4 | 4/200 | 4/200 | 380 | 182 | 2 | PFM | 17/M/71 | I | 4 | 4/200 | 4/200 | 772 | 169 | 2 | VH + NVG | 18/M/46 | N | 3 | 2/20 | 6/20 | 535 | 444 | 3 | None | 19/M/47 | N | 3 | 1/20 | 8/20 | 802 | 305 | 2 | None | 20/M/85 | N | 15 | 4/200 | 4/200 | 464 | 199 | 2 | None | 21/M/76 | N | 5 | 4/200 | 4/200 | 599 | 355 | 2 | None | 22/M/70 | N | 3 | 4/200 | 4/200 | 527 | 189 | 1 | None | 23/M/62 | I | 11 | 4/200 | 4/200 | 385 | 224 | 2 | PFM | 24/F/68 | I | 8 | 1/20 | 1/20 | 476 | 198 | 2 | None | 25/F/53 | N | 3 | 2/20 | 10/20 | 492 | 172 | 2 | None | 26/M/58 | N | 3 | 2/20 | 20/20 | 581 | 168 | 1 | None | 27/M/62 | N | 1 | 2/20 | 18/20 | 626 | 352 | 2 | None | 28/F/57 | N | 3 | 4/20 | 10/20 | 427 | 344 | 2 | None |
|
|
BCVA: best corrected visual acuity, HM: hand motion, CMT: central macular thickness, RCVA: retinochoroidal venous anastomosis, VH: vitreous hemorrhage, NVG: neovascular glaucoma, and PFM: preretinal fibrovascular membrane.
|